(Q33197377)

23 July 2017

title

Development of efficient viral vectors selective for vascular smooth muscle cells (English)

1 reference

23 July 2017

Lorraine M Work

1

0 references

Stuart A Nicklin

object named as

Stuart A Nicklin

2

0 references

Michael Hallek

6

object named as

Michael Hallek

1 reference

23 July 2017

Nick J R Brain

3

1 reference

23 July 2017

Kate L Dishart

4

1 reference

23 July 2017

Dan J Von Seggern

5

1 reference

23 July 2017

Hildegard Büning

7

1 reference

23 July 2017

Andrew H Baker

8

1 reference

23 July 2017

publication date

1 February 2004

1 reference

23 July 2017

1 reference

23 July 2017

volume

9

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

198-208

1 reference

Fighting restenosis after coronary angioplasty: contemporary and future treatment options

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Targets for gene therapy of vein grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Fifteen-Year Trends in Risk Severity and Operative Mortality in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Survival after coronary revascularization in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Prevention of vein graft failure: potential applications for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Gene transfer into vascular cells using adeno-associated virus (AAV) vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Adeno-associated virus-mediated gene transfer into rat carotid arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Use of phage display to identify novel peptides for targeted gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Targeting of peptides to restenotic vascular smooth muscle cells using phage display in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Decreased efficiency of adenovirus-mediated gene transfer in aging cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Tumor targeting with a selective gelatinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Peptide-Retargeted Adenovirus Encoding a Tissue Inhibitor of Metalloproteinase-1 Decreases Restenosis after Intravascular Gene Transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

A genetically modified adenoviral vector exhibits enhanced gene transfer of human smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Improved adenovirus vectors for infection of cardiovascular tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

Gene therapy for restenosis after balloon angioplasty and stenting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2003.11.006

1 reference

23 July 2017

1 reference